- Home
- SOUN vs PTCT Comparison
SOUN vs PTCT Comparison
Compare SOUN & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOUN | PTCT |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SOUN | PTCT |
|---|---|---|
| Price | $11.19 | $72.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $15.57 | ★ $73.76 |
| AVG Volume (30 Days) | ★ 24.3M | 1.3M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 8.94 |
| Revenue | $148,404,000.00 | ★ $1,779,150,000.00 |
| Revenue This Year | $102.51 | $129.80 |
| Revenue Next Year | $37.17 | N/A |
| P/E Ratio | ★ N/A | $8.11 |
| Revenue Growth | ★ 120.52 | 97.54 |
| 52 Week Low | $6.52 | $35.95 |
| 52 Week High | $22.17 | $87.50 |
Technical Indicators
Market Signals| Indicator | SOUN | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 38.43 |
| Support Level | $10.80 | $73.32 |
| Resistance Level | $12.31 | $77.87 |
| Average True Range (ATR) | 0.56 | 3.02 |
| MACD | 0.14 | -0.43 |
| Stochastic Oscillator | 54.29 | 17.88 |
Price Performance
Historical ComparisonAbout SOUN SoundHound AI Inc
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.